Quantifying the risk of disease reactivation after interferon and glatiramer acetate discontinuation in multiple sclerosis: The VIAADISC score-Reference-Cited by-同舟云学术

Quantifying the risk of disease reactivation after interferon and glatiramer acetate discontinuation in multiple sclerosis: The VIAADISC score

Published:2021-01-18 Issue:5 Volume:28 Page:1609-1616
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Eur J Neurol

Author:

Bsteh Gabriel¹^ORCID,Hegen Harald²^ORCID,Riedl Katharina¹,Altmann Patrick¹^ORCID,Auer Michael²,Berek Klaus²^ORCID,Di Pauli Franziska²,Ehling Rainer³,Kornek Barbara¹,Monschein Tobias¹,Rinner Walter¹,Schmied Christiane¹,Wurth Sebastian⁴,Zebenholzer Karin¹,Zinganell Anne²,Zrzavy Tobias¹^ORCID,Zulehner Gudrun¹,Deisenhammer Florian²,Rommer Paulus¹^ORCID,Leutmezer Fritz¹,Berger Thomas¹

Affiliation:

1. Department of Neurology Medical University of Vienna Vienna Austria

2. Department of Neurology Medical University of Innsbruck Innsbruck Austria

3. Department of Neurology Clinic for Rehabilitation Münster Münster Austria

4. Department of Neurology Medical University of Graz Graz Austria

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ene.14705

Reference30 articles.